Disease-Specific Mortality Among Patients With Intraductal Papillary Mucinous Neoplasm of the Pancreas  Kazumichi Kawakubo, Minoru Tada, Hiroyuki Isayama, Naoki Sasahira, Yousuke Nakai, Naminatsu Takahara, Rie Uchino, Tsuyoshi Hamada, Koji Miyabayashi, Keisuke Yamamoto, Suguru Mizuno, Dai Mohri, Hirofumi Kogure, Takashi Sasaki, Natsuyo Yamamoto, Kenji Hirano, Hideaki Ijichi, Keisuke Tateishi, Kazuhiko Koike  Clinical Gastroenterology and Hepatology  Volume 12, Issue 3, Pages 486-491 (March 2014) DOI: 10.1016/j.cgh.2013.06.032 Copyright © 2014 AGA Institute Terms and Conditions

Figure 1 (A) Cumulative incidence of pancreatic cancer–specific mortality before matching. The subhazard ratio for surgery was 1.51 (95% CI, 0.62–3.71; P = .364). (B) Cumulative incidence of pancreatic cancer–specific mortality after matching. The subhazard ratio for surgery was 0.43 (95% CI, 0.13–1.38; P = .157). Clinical Gastroenterology and Hepatology 2014 12, 486-491DOI: (10.1016/j.cgh.2013.06.032) Copyright © 2014 AGA Institute Terms and Conditions

Figure 2 Subgroup analysis of the adjusted hazard ratio for pancreatic cancer–specific mortality. Clinical Gastroenterology and Hepatology 2014 12, 486-491DOI: (10.1016/j.cgh.2013.06.032) Copyright © 2014 AGA Institute Terms and Conditions